Alizé Pharma launches Phase II clinical trial

AlizeePharma_3_actu
Alizé Pharma III raises €1.8 m in its first financing round
16 March 2015
Eye_actu
e(ye) brainraises EUR 1.3 million
3 February 2015

Alizé Pharma launches Phase II clinical trial

AlizeePharma_actu

AZP-531 will bedevelopped in patients with Prader-Willi syndrome.